Michael J Gallagher

Title: Michael J Gallagher: Innovator in Histamine Receptor Research

Introduction

Michael J Gallagher is a notable inventor based in Salem, NY (US). He has made significant contributions to the field of histamine receptor research, holding two patents that showcase his innovative work. His research focuses on novel splice variants of human histamine receptors, which have important implications for pharmacology.

Latest Patents

Gallagher's latest patents include the development of histamine receptor H3 polynucleotides and histamine receptor H4 polynucleotides. The patent for histamine receptor H3 describes novel splice variants that have deletions of portions of the N-terminal of the wild type H3 receptor. These splice variants are useful in methods for identifying agonists, inverse agonists, or antagonists of histamine action at the H3 receptor. Similarly, the patent for histamine receptor H4 outlines splice variants with deletions of portions of the N-terminal of the wild type H4 receptor, which are also valuable for identifying various modulators of histamine action.

Career Highlights

Michael J Gallagher is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to advancements in drug discovery and development, particularly in the area of histamine receptors.

Collaborations

Gallagher collaborates with Stephen L Yates, enhancing the research efforts in their field. Their combined expertise fosters innovation and drives forward the understanding of histamine receptors.

Conclusion

Michael J Gallagher's contributions to histamine receptor research through his patents and work at Merck & Company, Inc. highlight his role as an influential inventor in the pharmaceutical industry. His innovative approaches continue to pave the way for new therapeutic strategies.